ACAD vs CLOV
ACADIA Pharmaceuticals Inc (ACAD) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ACAD and CLOV stock pages for the full models.
Not investment advice.